Purified (azide-free) anti-APP C-Terminal Fragment [C1/6.1] and 2 more items

BioLegend Inc. has been awarded a contract by the University of Virginia, effective September 1, 2026, for the procurement of specialized laboratory reagents. The contract, identified as A207_PO-0475227, is valued at $219.00 and involves the delivery of three distinct monoclonal antibody products to Yuqi Guo at the University of Virginia in Virginia. The line items include purified, azide-free anti-mouse/rat I2-Amyloid (1-16) [M3.2] antibody at $78.40 per unit, purified azide-free anti-APP C-Terminal Fragment [C1/6.1] antibody at $78.40 per unit, and FITC (Fluorescein Isothiocyanate) conjugated anti-mouse Ly-6G [1A8] antibody at $62.30 per unit.

These research-grade antibody products are commonly utilized in immunological and neuroscience research applications. The procurement represents a single-transaction order for laboratory supplies rather than an ongoing services contract, as evidenced by the unit quantities and the cumulative contract value of $219.00. All materials are designated for delivery to the specified recipient at the University of Virginia, which serves as both the contracting organization and the place of performance for this award.